Why did the Air India Boeing 787 crash happen?
How will Trump's tariff threats impact the dollar?
What caused Oracle's stock to hit a record high?
Why was Sen. Alex Padilla forcibly removed at DHS press conference?
How will JetZero's factory affect North Carolina jobs?
Why is Google Cloud experiencing widespread outages?
How is Trump's blocking of California's EV mandate affecting the market?
Citi sees Gilead clinical holds as only ‘minor setback’
finance.yahoo.com/news/citi-sees-gilead-clinical-holds-142019013.html
In This Article:
Citi analyst Geoff Meacham keeps a Buy rating on Gilead (GILD) with a $125 price target after the company announced a clinical hold on its Phase 2 WONDERS trials evaluating the combination of GS-1720 and GS-4182 for once-weekly oral HIV treatment. The hold was initiated…
This story appeared on finance.yahoo.com, 2025-06-11 14:20:19.